References
- Parayath N , PawarG, AvachatC, MiyakeMM, BleierB, AmijiMM. Chapter 8: neurodegenerative disease. Nanomed. Inflammatory Dis.289–318 (2017).
- Bloom BR , de VriesNM, EbersbachG. Nonpharmacologic treatments for patients with Parkinson’s disease. Mov. Disord., 30(11), 1504–1520 (2015).
- Phillips MCL , MurtaghDKJ, GilbertsonLJ, AsztelyFJS, LynchCDP. Low-fat versus ketogenic diet in Parkinson’s disease: a pilot randomized controlled trial. Mov. Disord., 33(8), 1306–1314 (2018).
- Krikorian R , ShidlerMD, SummerSSet al. Nutritional ketosis for mild cognitive impairment in Parkinson’s disease: a controlled pilot trial. Clin. Park. Relat. Disord., 1, 41–47 (2019).
- Dewsbury LS , LimCK, SteinerGZ. The efficacy of ketogenic therapies in the clinical management of people with neurodegenerative disease: a systematic review. Adv. Nutr., 12(4), 1571–1593 (2021).
- Radloff LS . The CES-D scale: a self report depression scale for research in the general population. Psychol. Measurements, Applied 1, 385–401 (1977).
- Leentjens AFG , DujardinK, PontoneGM, StarksteinSE, WeintraubD, Martinez-MartinP. The Parkinson Anxiety Scale (PAS): development and validation of a new anxiety scale. Mov. Disord., 29(8), 1035–1043 (2014).
- The Wilcoxon Signed Rank Test. https://www.statisticshowto.datasciencecentral.com/wilcoxon-signed-rank-test/
- Harvey C , SchofieldG, WillidenM. The lived experiences of healthy adults following a ketogenic diet: a qualitative study. J. Holistic Performance (2018).
- Baruteau J , BroomfieldA, CrookVet al. Successful desensitisation in a patient with CRIM-positive infantile-onset Pompe disease. JIMD Rep., 12, 99–102 (2014).
- Bostock E , KirkbyK, TaylorB, HawrelakJ. Consumer reports of “Keto flu” associated with ketogenic diet. Front. Nutrition, 7(20), 1–6 (2020).
- Tuck CJ , StaudacherHM. The keto diet and the gut: cause for concern?Lancet Gastroenterol. Hepatol., 4(12), 908–909 (2019).
- What is the Keto headache, and how do you treat it? https://www.healthline.com/nutrition/keto-headache
- Mcdonald T , CervenkaM. Lessons learned from recent clinical trials of ketogenic diet therapies in adults. Curr. Opin. Clin. Nutr. Metab. Care.418–424 (2019).
- Gibson AA , ErogluEI, RooneyKet al. Urine dipsticks are not accurate for detecting mild ketosis during a severely energy restricted diet. Obes. Sci. Pract., 6(5), 544–551 (2020).
- Irvin CW . The ketogenic diet for neurological disorders (2019). https://keto-mojo.com/article/health-ketogenic-diet-neurological-disorders/
- Storoni M , PlantGT. The therapeutic potential of the ketogenic diet in treating progressive multiple sclerosis. Mult. Scler. Int., 2015, 681289 (2015).
- Fahn S. E. R. L. Updrs Program Members . The United Parkinson’s Rating Scale. Recent Devel. Parkinsons Dis., 2, 153–163 (1987).
- Dragsted LOP, Perozzi G. Biomarkers in Food and Nutrition Research 2021. (2021). https://genesandnutrition.biomedcentral.com/track/pdf/10.1186/s12263-021-00697-1.pdf
- Picó C , SerraF, RodríguezAM, KeijerJ, PalouA. Biomarkers of nutrition and health: new tools for new approaches. Nutrients, 11(5), 1092 (2019).
- Leehey M , LuoS, SharmaSet al. Association of metabolic syndrome and change in Unified Parkinson’s Disease Rating Scale scores. Neurology, 89(17), 1789–1794 (2017).
- Chen R , ZhuX, WrightLet al. Suicidal ideation and attempted suicide amongst Chinese transgender persons: national population study. J. Affect. Disord., 245, 1126–1134 (2019).
- Fabbri M , CoelhoM, GuedesLCet al. Response of non-motor symptoms to levodopa in late-stage Parkinson’s disease: results of a levodopa challenge test. Parkinsonism. Relat. Disord., 39, 37–43 (2017).
- Augustin K , KhabbushA, WilliamsSet al. Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. Lancet. Neurol., 17, 84–93 (2018).